Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 786.23 USD -3.15% Market Closed
Market Cap: 747.3B USD
Have any thoughts about
Eli Lilly and Co?
Write Note

Eli Lilly and Co
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eli Lilly and Co
Cash & Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
ZTS

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$3.4B
CAGR 3-Years
-4%
CAGR 5-Years
17%
CAGR 10-Years
1%
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$8.2B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$7.9B
CAGR 3-Years
-16%
CAGR 5-Years
-24%
CAGR 10-Years
5%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$14.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
3%
Zoetis Inc
NYSE:ZTS
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
-19%
CAGR 5-Years
-1%
CAGR 10-Years
11%

See Also

What is Eli Lilly and Co's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.4B USD

Based on the financial report for Sep 30, 2024, Eli Lilly and Co's Cash & Cash Equivalents amounts to 3.4B USD.

What is Eli Lilly and Co's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
1%

Over the last year, the Cash & Cash Equivalents growth was 41%. The average annual Cash & Cash Equivalents growth rates for Eli Lilly and Co have been -4% over the past three years , 17% over the past five years , and 1% over the past ten years .

Back to Top